Cannabis Stocks Retreat On New Rescheduling Order Developments: What's Going On?

Zinger Key Points
  • Several reports from last week indicated the DEA would move to reclassify marijuana as a less dangerous drug.
  • DEA Administrator Anne Milgram reportedly failed to sign the rescheduling order this week.

The Biden Administration’s plan to reclassify cannabis as a Schedule III drug may be losing momentum following new reports suggesting the administrator of the U.S. Drug Enforcement Administration (DEA) failed to sign the rescheduling order.

What Happened: Several reports from last week indicated that the DEA would move to reclassify marijuana as a less dangerous drug. Although the proposal wouldn’t legalize cannabis for recreational use, it acknowledged that cannabis has medical benefits and places it in a category that recognizes it as having less potential for abuse.

The DEA was expected to move forward with its plans this week to remove cannabis as a Schedule 1 drug, where it currently sits alongside heroin and LSD, but new reports suggest the proposal has stalled.

According to an X post on Monday from Newsweek’s Kevin Sabet, DEA Administrator Anne Milgram failed to sign the rescheduling order.

“BIG: I can now say with full confidence that the Administrator of DEA, Anne Milgram, did NOT sign the rescheduling order, breaking with five decades of precedent and established law and regulations,” Sabet said in the post, citing two confidential sources inside the DEA and another outside source with knowledge on the matter.

Don’t Miss: Criminal Defense Lawyers To Biden: Release Pot Prisoners As DEA Moves To Reclassify Cannabis

Cannabis stocks got a lift last week in anticipation of the rescheduling order. The broader cannabis space pulled back Monday afternoon following new rescheduling order developments.

Here’s a look at some of the biggest movers in the cannabis space on Monday, at market close:

  • Canopy Growth Corp CGC: Down 5.08%
  • Tilray Brands, Inc TLRY: Down 2.38%
  • Curaleaf Hldgs Inc CURLF: Down 0.35%
  • Trulieve Cannabis Corp TCNNF: Down 8.78%
  • Green Thumb Industries Inc GTBIF: Down 5.15%
  • AdvisorShares Pure US Cannabis ETF MSOS: Down 2.79%
  • AdvisorShares Pure Cannabis ETF YOLO: Down 1.47%

Check This Out: Cannabis Reform Advocate Champions Change, Looks To Expand Prophet Across The Globe

Photo: 7raysmarketing from Pixabay

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisGovernmentNewsRegulationsPoliticsLegalMoverswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Top Cannabis Event In New Jersey

Join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don’t miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off!